Manufacturing Korean Cosmetics for the U.S. Market - OEM, ODM, OBM, and Licensing Models

 

Manufacturing Korean Cosmetics for the U.S. Market

OEM, ODM, OBM, and Licensing Models

Korean cosmetics continue to gain strong global recognition, and many U.S. companies are now exploring opportunities to develop, manufacture, import, and distribute K-Beauty products through Korean cosmetic manufacturers. Common business models include OEM, ODM, OBM, and Licensing. Each structure offers different levels of control, responsibility, cost, speed to market, and regulatory exposure.

For any U.S. company planning to import cosmetics manufactured in Korea, the most important issue is determining who will act as the brand owner, importer, distributor, and “Responsible Person” under U.S. cosmetic regulations. The company whose name appears on the product label may carry significant responsibility for product safety, labeling, claims, adverse event reporting, and FDA-related compliance.

1. Basic U.S. Regulatory Understanding

In the United States, most cosmetic products do not require FDA pre-market approval before being sold. However, this does not mean cosmetics can be imported or sold without compliance. Cosmetic products must be safe for consumer use, properly labeled, and free from false or misleading claims.

Since the implementation of the Modernization of Cosmetics Regulation Act of 2022, known as MoCRA, compliance requirements have become much more important. Cosmetic manufacturers and processors may be required to register their facilities with the FDA. In addition, the Responsible Person must submit product listings, maintain safety substantiation records, and report serious adverse events when required.

Products that make drug-like claims may be regulated as drugs or cosmetic-drug products. For example, products claiming to treat acne, eczema, hair loss, melasma, infection, or medical skin conditions may fall outside the category of ordinary cosmetics. Sunscreen products with SPF claims are generally regulated as OTC drug products in the United States.

2. Comparison of OEM, ODM, OBM, and Licensing

OEM: Original Equipment Manufacturing

Under an OEM model, the U.S. company develops or controls the brand concept, product direction, packaging, and sometimes the formula. The Korean manufacturer produces the product according to the client’s specifications.

Advantages:
OEM is ideal for building a private brand with stronger identity and product differentiation. It gives the U.S. company more control over formulation, packaging, positioning, and long-term brand value.

Disadvantages:
OEM often requires higher development costs, longer lead times, higher minimum order quantities, and more responsibility for formulation review, product claims, labeling, and safety documentation.

ODM: Original Design Manufacturing

Under an ODM model, the Korean manufacturer provides existing formulas, product concepts, textures, packaging options, and samples. The U.S. company selects and customizes products under its own brand.

Advantages:
ODM is usually the fastest and most practical model for new importers. It allows a U.S. company to enter the market with proven Korean cosmetic formulas while focusing on branding, packaging, marketing, and distribution.

Disadvantages:
Product differentiation may be limited because similar formulas may be available to other buyers. The formula is usually owned by the manufacturer, so exclusivity and ownership rights must be clearly reviewed.

OBM: Original Brand Manufacturing

Under an OBM model, the Korean manufacturer or Korean brand owner already has its own finished brand. The U.S. company imports, distributes, or represents that brand in the United States.

Advantages:
OBM reduces product development burden. If the Korean brand already has recognition, reviews, or success in other markets, it can be easier to promote and sell.

Disadvantages:
The U.S. company may not own the brand. Profit margins may be lower, and other distributors may enter the market unless exclusive distribution rights are secured.

Licensing

Under a Licensing model, the U.S. company obtains permission to use a Korean brand, trademark, character, technology, formulation, or product concept under a formal licensing agreement.

Advantages:
Licensing can be powerful when the Korean brand or intellectual property already has market recognition. Exclusive rights can create strong business value in the U.S. market.

Disadvantages:
Licensing agreements can be complex. Royalty terms, territory, duration, exclusivity, quality control, trademark rights, marketing obligations, and regulatory responsibilities must be clearly defined.

3. General Process for U.S. Importation

The typical process begins with product planning and regulatory classification. The U.S. company should first determine whether the product is a general cosmetic, an OTC drug, or a cosmetic-drug combination. This classification depends not only on the ingredients but also on labeling, advertising, website descriptions, and marketing claims.

After the product category is confirmed, the U.S. company should select a qualified Korean manufacturer with experience in U.S. exports. Important qualifications include FDA/MoCRA awareness, facility registration capability, quality control systems, INCI ingredient documentation, stability testing, microbial testing, challenge testing, COA preparation, and English labeling support.

The next step is product development. This may include signing an NDA, reviewing formulas, requesting samples, adjusting texture, fragrance, color, packaging, and confirming minimum order quantities, pricing, lead time, and payment terms.

Before mass production, the U.S. label must be reviewed carefully. U.S. cosmetic labels should include product identity, net contents, ingredient declaration using proper INCI names, distributor or Responsible Person information, country of origin, directions, warnings, lot number, and appropriate contact information for adverse event reporting.

After label approval, the manufacturer proceeds with production and quality control. The U.S. importer should request key documents such as Commercial Invoice, Packing List, Certificate of Origin, Certificate of Analysis, SDS or MSDS, ingredient list, safety documentation, batch records, product photos, label artwork, and manufacturer information.

The shipment is then exported from Korea and imported into the United States through a customs broker. The broker files the necessary entry documents with CBP and, when applicable, FDA. If there are no issues, the goods are released and delivered to a warehouse, 3PL, Amazon facility, retail distributor, spa, beauty store, or direct-to-consumer fulfillment center.

4. Key Compliance Areas

The most common compliance risks include incorrect product classification, drug-like marketing claims, improper ingredient names, restricted or unapproved color additives, incomplete labeling, missing manufacturer information, insufficient safety documentation, and lack of clarity regarding the Responsible Person.

Color cosmetics require special attention because color additives approved in Korea may not always be permitted for the same use in the United States. Eye-area products, lip products, and bright pigment products should be reviewed carefully.

Marketing claims must also be controlled. Claims such as “hydrates,” “smooths,” “improves the appearance of fine lines,” and “brightening appearance” are generally safer cosmetic-style claims. Claims such as “treats acne,” “heals eczema,” “removes melasma,” “regenerates skin cells,” or “cures inflammation” may create drug-related regulatory concerns.

5. Recommended Strategy for New U.S. Importers

For a company entering the U.S. K-Beauty market for the first time, the most practical approach is usually an ODM model with the U.S. company’s own private label brand. This allows faster product launch, lower development burden, and access to proven Korean cosmetic formulations.

Recommended starter products include toner, serum, moisturizer, cleanser, cleansing balm, sheet mask, body lotion, lip balm without SPF, and general hair essence without hair-growth claims.

Products that should be approached with caution include sunscreen, acne treatment, whitening treatment, hair-growth products, anti-dandruff shampoo, antibacterial products, eyelash growth serum, injectable-style ampoules, and products designed for medical or clinical use.

6. Contractual Issues to Review

Before placing an order, the U.S. company should clearly define formula ownership, trademark rights, packaging rights, exclusivity, territory, minimum order quantity, payment terms, delivery schedule, quality standards, defective product policy, recall responsibility, adverse event cooperation, document support, product liability insurance, and confidentiality obligations.

For OBM or Licensing models, the U.S. company should also confirm whether it has exclusive rights for the United States, online sales rights, Amazon sales rights, TikTok Shop rights, retail distribution rights, and marketing usage rights.

7. Practical Conclusion

A U.S. company can successfully import Korean cosmetics through OEM, ODM, OBM, or Licensing structures. However, the best model depends on the company’s business goal.

ODM is usually the fastest and safest entry model.
OEM is best for building a unique long-term private brand.
OBM is useful when importing an existing Korean brand.
Licensing is valuable when the Korean brand, trademark, or technology already has strong market appeal.

The most important success factors are product selection, regulatory classification, labeling compliance, reliable Korean manufacturing partners, strong documentation, clear contracts, and a well-planned U.S. distribution and marketing strategy.